Answers are grounded in this paper and cite their sources.
Comparison of these results with those of studies comparing healthy glycolytic with oxidative muscle suggests that these differences may be attributable to greater type II fiber expression in COPD muscle, as mitochondria within this fiber type have respiratory function similar to that of mitochondria from type I fibers, and yet are intrinsically prone to greater release of H(2)O(2) and more resistant to PTP opening. These results thus argue against the presence of pathological mitochondrial alterations in this category of patients with COPD.
No takes yet. Share an insight, caveat, or question.
Picard et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: